Department of Gynecology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Rev Bras Ginecol Obstet. 2023 Oct;45(10):e584-e593. doi: 10.1055/s-0043-1772592. Epub 2023 Nov 9.
To evaluate the efficacy and outcomes of the surgical treatment for pelvic organ prolapse (POP) in stages III and IV by sacrospinous ligament fixation (SSLF) or uterosacral ligament suspension (USLS) by comparing anatomical and subjective cure rates and quality-of-life parameters (through the version validated for the Portuguese language of the Prolapse Quality of Life [P-QoL] questionnaire) under two definitions: genital prolapse Ba, Bp, and C < -1 (stage I) and Ba, Bp, and C ≤ 0 (stage II).
After we obtained approval from the Ethics Committee (under CAAE 0833/06) and registered the study in ClinicalTrials.gov (NCT01347021), 51 patients were randomized into two groups: the USLS group (N = 26) and the SSLF group (N = 25), with follow-up 6 and 12 months after the procedures.
There was a significant improvement in the P-QoL score and anatomical measurements of all compartments in both groups after 12 months ( < 0.001). The anatomical cure rates in the USLS and SSLF groups, considering stage 1, were of 34.6% and 40% (anterior) respectively; of 100% both for groups (apical); and of 73.1% and 92% (posterior) respectively. The rates of adverse outcomes were of 42% (N = 11) and 36% (N = 11) for the USLS and SSLF groups respectively ( = 0.654), and those outcomes were excessive bleeding, bladder perforation (intraoperative) or gluteal pain, and urinary infection (postoperative), among others, without differences between the groups.
High cure rates in all compartments were observed according to the anatomical criterion (stage I), without differences in P-QoL scores and complications either with USLS or SSLF for the surgical treatment of accentuated POP.
通过比较经骶骨阴道固定术(SSLF)或悬吊带子宫骶骨固定术(USLS)治疗 III 期和 IV 期盆腔器官脱垂(POP)的解剖学和主观治愈率以及生活质量参数(通过验证适合葡萄牙语的脱垂生活质量问卷 [P-QoL]),评估两种定义下(生殖器脱垂 Ba、Bp 和 C<−1(I 期)和 Ba、Bp 和 C≤0(II 期))的手术治疗效果和结局。
在获得伦理委员会的批准(根据 CAAE 0833/06)并在 ClinicalTrials.gov 注册研究(NCT01347021)后,我们将 51 名患者随机分为两组:USLS 组(N=26)和 SSLF 组(N=25),术后 6 个月和 12 个月进行随访。
两组患者的 P-QoL 评分和所有隔室的解剖学测量在 12 个月后均有显著改善(<0.001)。USLS 和 SSLF 组中,考虑到 I 期,解剖学治愈率分别为 34.6%和 40%(前);两组均为 100%(顶);分别为 73.1%和 92%(后)。USLS 和 SSLF 组的不良结局发生率分别为 42%(N=11)和 36%(N=11)(=0.654),这些结局包括过度出血、膀胱穿孔(术中)或臀痛和尿路感染(术后)等,两组之间无差异。
根据解剖学标准(I 期),所有隔室均观察到高治愈率,USLS 或 SSLF 治疗重度 POP 的 P-QoL 评分和并发症无差异。